References
- Popovic MM, Schlenker MB, Thiruchelvam D, Redelmeier DA: Serious Adverse Events of Oral and Topical Carbonic Anhydrase Inhibitors. JAMA Ophthalmol 2022, 140(3):235-242.
- Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, Bilker WB, Pettitt D: Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 2003, 349(17):1628-1635.
- Beckwith-Cohen B, Bentley E, Gasper DJ, McLellan GJ, Dubielzig RR: Keratitis in six dogs after topical treatment with carbonic anhydrase inhibitors for glaucoma. J Am Vet Med Assoc 2015, 247(12):1419-1426.
- Inoue K, Okugawa K, Kato S, Inoue Y, Tomita G, Oshika T, Amano S: Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy. J Glaucoma 2003, 12(6):480-485.
- Shim J, Kim SA, Seo K, Kang S: Delayed periocular dermatitis as a rare side-effect of topical anti-glaucoma eyedrop instillation in two Shih-Tzu dogs with atopic dermatitis. J Vet Sci 2023, 24(1):e6.
- Aalto-Korte K: Contact allergy to dorzolamide eyedrops. Contact Dermatitis 1998, 39(4):206.
- Delaney YM, Salmon JF, Mossa F, Gee B, Beehne K, Powell S: Periorbital dermatitis as a side effect of topical dorzolamide. Br J Ophthalmol 2002, 86(4):378-380.
- Holdiness MR: Contact dermatitis to topical drugs for glaucoma. Am J Contact Dermat 2001, 12(4):217-219.
- Kalavala M, Statham BN: Allergic contact dermatitis from timolol and dorzolamide eye drops. Contact Dermatitis 2006, 54(6):345.
- Kluger N, Guillot B, Raison-Peyron N: Systemic contact dermatitis to dorzolamide eye drops. Contact Dermatitis 2008, 58(3):167-168.
- Lee SJ, Kim M: Allergic contact dermatitis caused by dorzolamide eyedrops. Clin Ophthalmol 2015, 9:575-577.
- Linares Mata T, Pardo Sanchez J, de la Cuadra Oyanguren J: Contact dermatitis caused by allergy to dorzolamide. Contact Dermatitis 2005, 52(2):111-112.
- Mancuso G, Berdondini RM: Allergic contact blepharoconjunctivitis from dorzolamide. Contact Dermatitis 2001, 45(4):243.
- Mitsuyama S, Abe F, Higuchi T: Allergic contact dermatitis due to dorzolamide eyedrops. Contact Dermatitis 2021, 84(1):58-59.
- Orsini D, D’Arino A, Pigliacelli F, Assorgi C, Latini A, Cristaudo A: Allergic contact dermatitis to dorzolamide and benzalkonium chloride. Postepy Dermatol Alergol 2018, 35(5):538-539.
- Kim M, Jang H, Rho S: Risk factors for periorbital dermatitis in patients using dorzolamide/timolol eye drops. Sci Rep 2021, 11(1):17896.
- Trubiano JA, Ostrov DA, Phillips EJ: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Carbonic Anhydrase Inhibitors: Epidemiology, Genetics, and Insights into Mechanisms. J Allergy Clin Immunol Pract 2019, 7(8):2854-2856.
- Jachiet M, Bellon N, Assier H, Amsler E, Gaouar H, Pecquet C, Bourrain JL, Bégon E, Chosidow O, Francès C et al: Cutaneous adverse drug reaction to oral acetazolamide and skin tests. Dermatology 2013, 226(4):347-352.
- Basketter DA, Marriott M, Gilmour NJ, White IR: Strong irritants masquerading as skin allergens: the case of benzalkonium chloride. Contact Dermatitis 2004, 50(4):213-217.
- Inoue K: Managing adverse effects of glaucoma medications. Clin Ophthalmol 2014, 8:903-913.
- Cuffaro D, Nuti E, Rossello A: An overview of carbohydrate-based carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2020, 35(1):1906-1922.
- Han H, Li S, Xu M, Zhong Y, Fan W, Xu J, Zhou T, Ji J, Ye J, Yao K: Polymer – and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives. Adv Drug Deliv Rev 2023, 196:114770.
- Ludriksone L, Elsner P: Adverse Reactions to Sunscreens. Curr Probl Dermatol 2021, 55:223-235.
- Franceschini F, Bottau P, Caimmi S, Cardinale F, Crisafulli G, Liotti L, Saretta F, Bernardini R, Mori F, Caffarelli C: Mechanisms of hypersensitivity reactions induced by drugs. Acta Biomed 2019, 90(3-s):44-51.
- Jeimy S, Wong T, Ben-Shoshan M, Copaescu AM, Isabwe GAC, Ellis AK: Drug allergy. Allergy Asthma Clin Immunol 2025, 20(Suppl 3):78.
- Khan DA, Solensky R: Drug allergy. J Allergy Clin Immunol 2010, 125(2 Suppl 2):S126-137.
- Tangamornsuksan W, Lohitnavy M: Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis. Pharmacogenomics J 2019, 19(3):286-294.
- Hume-Smith KM, Groth AD, Rishniw M, Walter-Grimm LA, Plunkett SJ, Maggs DJ: Anaphylactic events observed within 4 h of ocular application of an antibiotic-containing ophthalmic preparation: 61 cats (1993-2010). J Feline Med Surg 2011, 13(10):744-751.
- Scherrer MAR, Abreu É P, Rocha VB: Neomycin: sources of contact and sensitization evaluation in 1162 patients treated at a tertiary service. An Bras Dermatol 2023, 98(4):487-492.
- Su SC, Hung SI, Fan WL, Dao RL, Chung WH: Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation. Int J Mol Sci 2016, 17(11).